Skip to main content
TipRanks
Go Ultimate75% OFF

Silva Raj De Insider Profile

4 Followers

Silva Raj De, President & COO at Bausch Health Companies, holds 1.25M shares in Venus Concept (Ticker: VERO), holds 258.39K shares in Endo International (Ticker: ENDPQ), holds 259.77K shares in Bausch Health Companies (Ticker: BHC). Most recently, Silva Raj De Bought ― shares of Venus Concept on Nov 22, 2022 for an estimated value of $250.00K.

Silva Raj De's Trading History

VERO
Venus Concept
Nov 22, 2022―Informative Buy250.00K$377.50K
ENDPQ
Endo International
Mar 07, 2016―Informative Buy100.13K$3.10K
BHC
Bausch Health Companies
Jan 08, 2013President & COOUninformative Sell―$2.17M
AMAG
Amag Pharmaceuticals
May 29, 2012―Uninformative Buy―$203.80K

You May Also Like

Silva Raj De insider profile FAQ

What is the percentage of profitable transactions made by Silva Raj De?
The percentage of profitable transactions made by Silva Raj De is 0%.
What is the average return per transaction made by Silva Raj De?
The average return per transaction made by Silva Raj De is -63.80%.
What stocks does Silva Raj De hold?
Silva Raj De holds: BHC, ENDPQ, VERO, AMAG stocks.
What was Silva Raj De’s latest transaction?
Silva Raj De’s latest transaction was an Informative Buy of $250.00K.
What was Silva Raj De's most profitable transaction?
Silva Raj De’s most profitable transaction was an Informative Buy of VERO stock on November 22, 2022. The return on the trade was -47.50%.
What is Silva Raj De's role in Bausch Health Companies?
Silva Raj De's role in Bausch Health Companies is President & COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.